Ann: First Patient Enrolled in Australia in global Phase 2 Trial, page-2

Does anyone know if when they say that they expect to enrol 60 patients, if that’s a global total or just for the Australian study? Given that the study will go for 12 months, it’s most likely the end of next year, at the earliest, before the results of the trials are announced.

Given the cash they have available, it is also most unlikely that they will have sufficient funds to complete the trial. It’s almost a certain that there will be a capital raising during the next 12 months and at a time when the share price will be at an all time low. In their last phase 2 trial with PBT2, there was a strong run up in share price to over $1.00. Not sure we will see the same trend this time around.